Pfizer Operating Income 2010-2024 | PFE

Pfizer operating income for the twelve months ending September 30, 2024 was $4.719B, a 52.56% decline year-over-year.

  • Pfizer annual operating income for 2023 was $0.222B, a 99.36% decline from 2022.
  • Pfizer annual operating income for 2022 was $34.944B, a 79.82% increase from 2021.
  • Pfizer annual operating income for 2021 was $19.433B, a 135.55% increase from 2020.

Pfizer Operating Income 2010-2024 | PFE

  • Pfizer annual operating income for 2023 was $0.222B, a 99.36% decline from 2022.
  • Pfizer annual operating income for 2022 was $34.944B, a 79.82% increase from 2021.
  • Pfizer annual operating income for 2021 was $19.433B, a 135.55% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B